The Roles of NcRNAs and Histone-modifiers in Regulating Breast Cancer Stem Cells

Overview

Journal Protein Cell

Publisher Oxford University Press

Specialties Biochemistry
Cell Biology

Date 2015 Sep 10

PMID 26349457

Citations 23

Authors

Zhiju Zhao

Shu Li

Erwei Song

Suling Liu

Affiliations

Soon will be listed here.

Abstract

Cancer stem cells (CSCs), a subpopulation of cancer cells with ability of initiating tumorigenesis, exist in many kinds of tumors including breast cancer. Cancer stem cells contribute to treatment resistance and relapse. Conventional treatments only kill differentiated cancer cells, but spare CSCs. Combining conventional treatments with therapeutic drugs targeting to CSCs will eradicate cancer cells more efficiently. Studying the molecular mechanisms of CSCs regulation is essential for developing new therapeutic strategies. Growing evidences showed CSCs are regulated by non-coding RNA (ncRNA) including microRNAs and long non-coding RNAs (lncRNAs), and histone-modifiers, such as let-7, miR-93, miR-100, HOTAIR, Bmi-1 and EZH2. Herein we review the roles of microRNAs, lncRNAs and histone-modifiers especially Polycomb family proteins in regulating breast cancer stem cells (BCSCs).

Citing Articles

Long non-coding RNA involved in the carcinogenesis of human female cancer - a comprehensive review.

Afroze N, Sundaram M, Haque S, Hussain A Discov Oncol. 2025; 16(1):122.

PMID: 39912983 PMC: 11803034. DOI: 10.1007/s12672-025-01848-1.

MUSCLE: multi-view and multi-scale attentional feature fusion for microRNA-disease associations prediction.

Ji B, Zou H, Xu L, Xie X, Peng S Brief Bioinform. 2024; 25(3).

PMID: 38605642 PMC: 11009512. DOI: 10.1093/bib/bbae167.

HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer.

Raju G, Pavitra E, Bandaru S, Varaprasad G, Nagaraju G, Malla R Mol Cancer. 2023; 22(1):65.

PMID: 36997931 PMC: 10061914. DOI: 10.1186/s12943-023-01765-3.

Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells.

Chen W, Zhang L, Liu S, Chen C Cells. 2022; 11(19).

PMID: 36230903 PMC: 9562239. DOI: 10.3390/cells11192941.

lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment.

Jin H, Du W, Huang W, Yan J, Tang Q, Chen Y Mol Ther Nucleic Acids. 2021; 25:613-637.

PMID: 34589282 PMC: 8463317. DOI: 10.1016/j.omtn.2021.08.005.

References

Cha T, Zhou B, Xia W, Wu Y, Yang C, Chen C . Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science. 2005; 310(5746):306-10. DOI: 10.1126/science.1118947. View

Liu S, Dontu G, Mantle I, Patel S, Ahn N, Jackson K . Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006; 66(12):6063-71. PMC: 4386278. DOI: 10.1158/0008-5472.CAN-06-0054. View

Clement V, Sanchez P, De Tribolet N, Radovanovic I, Ruiz i Altaba A . HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol. 2007; 17(2):165-72. PMC: 1855204. DOI: 10.1016/j.cub.2006.11.033. View

Ma S, Chan K, Hu L, Lee T, Wo J, Ng I . Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology. 2007; 132(7):2542-56. DOI: 10.1053/j.gastro.2007.04.025. View

Ma L, Teruya-Feldstein J, Weinberg R . Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449(7163):682-8. DOI: 10.1038/nature06174. View

Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C . let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007; 131(6):1109-23. DOI: 10.1016/j.cell.2007.10.054. View

Ginestier C, Wicha M . Mammary stem cell number as a determinate of breast cancer risk. Breast Cancer Res. 2007; 9(4):109. PMC: 2206714. DOI: 10.1186/bcr1741. View

Schatton T, Murphy G, Frank N, Yamaura K, Waaga-Gasser A, Gasser M . Identification of cells initiating human melanomas. Nature. 2008; 451(7176):345-9. PMC: 3660705. DOI: 10.1038/nature06489. View

Yang Z, Ho D, Ng M, Lau C, Yu W, Ngai P . Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell. 2008; 13(2):153-66. DOI: 10.1016/j.ccr.2008.01.013. View

10.

Fasano C, Dimos J, Ivanova N, Lowry N, Lemischka I, Temple S . shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development. Cell Stem Cell. 2008; 1(1):87-99. DOI: 10.1016/j.stem.2007.04.001. View

11.

Wright M, Robles A, Herschkowitz J, Hollingshead M, Anver M, Perou C . Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1. Mol Cancer. 2008; 7:29. PMC: 2329667. DOI: 10.1186/1476-4598-7-29. View

12.

Bu P, Chen K, Huan Chen J, Wang L, Walters J, Shin Y . A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. Cell Stem Cell. 2013; 12(5):602-15. PMC: 3646336. DOI: 10.1016/j.stem.2013.03.002. View

13.

Kim E, Kim M, Woo D, Shin Y, Shin J, Chang N . Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell. 2013; 23(6):839-52. PMC: 4109796. DOI: 10.1016/j.ccr.2013.04.008. View

14.

Cai W, Wei T, Luo Q, Wu Q, Liu Q, Yang M . The Wnt-β-catenin pathway represses let-7 microRNA expression through transactivation of Lin28 to augment breast cancer stem cell expansion. J Cell Sci. 2013; 126(Pt 13):2877-89. DOI: 10.1242/jcs.123810. View

15.

Schade B, Lesurf R, Sanguin-Gendreau V, Bui T, Deblois G, OToole S . β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression. Cancer Res. 2013; 73(14):4474-87. DOI: 10.1158/0008-5472.CAN-12-3925. View

16.

Song S, Poliseno L, Song M, Ala U, Webster K, Ng C . MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell. 2013; 154(2):311-324. PMC: 3767157. DOI: 10.1016/j.cell.2013.06.026. View

17.

Tu Y, Gao X, Li G, Fu H, Cui D, Liu H . MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res. 2013; 73(19):6046-55. DOI: 10.1158/0008-5472.CAN-13-0358. View

18.

Michalak E, Nacerddine K, Pietersen A, Beuger V, Pawlitzky I, Cornelissen-Steijger P . Polycomb group gene Ezh2 regulates mammary gland morphogenesis and maintains the luminal progenitor pool. Stem Cells. 2013; 31(9):1910-20. DOI: 10.1002/stem.1437. View

19.

Jung H, Jun S, Lee M, Kim H, Wang X, Ji H . PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation. Mol Cell. 2013; 52(2):193-205. PMC: 4040269. DOI: 10.1016/j.molcel.2013.08.028. View

20.

Schwartz Y, Pirrotta V . A new world of Polycombs: unexpected partnerships and emerging functions. Nat Rev Genet. 2013; 14(12):853-64. DOI: 10.1038/nrg3603. View